tau 284 has been researched along with loratadine in 1 studies
Studies (tau 284) | Trials (tau 284) | Recent Studies (post-2010) (tau 284) | Studies (loratadine) | Trials (loratadine) | Recent Studies (post-2010) (loratadine) |
---|---|---|---|---|---|
52 | 18 | 21 | 1,317 | 462 | 339 |
Protein | Taxonomy | tau 284 (IC50) | loratadine (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 0.016 | |
Histamine H1 receptor | Homo sapiens (human) | 0.23 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.245 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1717 | |
Bile acid receptor | Homo sapiens (human) | 3.07 | |
Sodium-dependent neutral amino acid transporter B(0)AT2 | Homo sapiens (human) | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikezawa, Z; Inomata, N; Tatewaki, S | 1 |
1 other study(ies) available for tau 284 and loratadine
Article | Year |
---|---|
Multiple H1-antihistamine-induced urticaria.
Topics: Administration, Oral; Adult; Drug Eruptions; Female; Histamine; Histamine H1 Antagonists; Humans; Immunologic Tests; Leukotriene B4; Loratadine; Piperidines; Pyridines; Skin Tests; Terfenadine; Urticaria | 2009 |